George Kemble

Chair, Sagimet Biosciences Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 14, 2026Sold 350,987 shares at $10.23 of Sagimet Biosciences Inc.³
Aug 14, 2026Exercised options 24,369 shares at $6.36 of Sagimet Biosciences Inc.³
Aug 14, 2026Exercised options 326,618 shares at $6.36 of Sagimet Biosciences Inc.³
Aug 11, 2026Sold 20,206 shares at $9.95 of Sagimet Biosciences Inc.⁴
Aug 11, 2026Exercised options 10,455 shares at $6.36 of Sagimet Biosciences Inc.⁴
Aug 11, 2026Exercised options 9,751 shares at $6.36 of Sagimet Biosciences Inc.⁴
Jul 20, 2026Sold 18,844 shares at $7.46 of Sagimet Biosciences Inc.⁵
Nov 20, 2025Sold 37,688 shares at $7.69 of Sagimet Biosciences Inc.⁶
Jul 23, 2024Sold 23,625 shares at $3.17 of Sagimet Biosciences Inc.⁷
Jul 19, 2024Sold 14,062 shares at $3.10 of Sagimet Biosciences Inc.⁸
Nov 17, 2023Granted 150,750 shares of Sagimet Biosciences Inc.⁹
Sep 7, 2023Exercised options 5,630 shares at $0.79 of Sagimet Biosciences Inc.¹⁰

The numbers on this page point here. Each one links to the record it came from.